Skip to main content
. 2019 Jan 17;9(1):e023412. doi: 10.1136/bmjopen-2018-023412

Table 4.

Estimated numbers of TB cases prevented by LTBI treatment of immigrants during the first 5 years after arrival in Norway, 2008–2011

Country of origin (WHO-estimated TB incidence rate per 100 000)* TB notification (<40 years) LTBI treatment (<40 years)† Time of LTBI treatment after arrival (months) LTBI treatment >12 months after arrival Incident TB cases prevented by LTBI treatment‡ Additional preventable incident TB cases if all LTBI treatments were initiated within 6 or 12 months after arrival
<6 7–12 13–60
(n) n (%) (n) (n) (n) (%) n, range 6 months (%) 12 months (%)
By country
 Myanmar (369) 18 54 (21) 23 15 16 30 3 (4–2) 21 9
 Philippines (288) 64 200 (10) 61 68 71 35 2 (3–1) 57 11
 Somalia (274) 252 391 (19) 64 113 215 55 19 (27–13) 38 15
 Pakistan (270) 12 16 (3) 4 4 9 52 0.2 (0.2–0.1) 22 7
 Ethiopia (207) 46 108 (17) 13 37 58 54 3 (5–2) 15 8
 Afghanistan (189) 44 159 (11) 32 54 74 46 3 (4–2) 18 7
 Thailand (171) 20 53 (7) 13 15 25 47 0.5 (0.7–0.3) 30 4
 India (167) 18 21 (3) 6 8 7 33 0.2 (0.3–0.2) 10 2
 Vietnam (140) 12 26 (15) 8 10 8 32 0.5 (0.6–0.3) 99 4
 Eritrea (78) 82 195 (10) 21 60 113 58 3 (6–2) 42 16
 Horn of Africa§ 380 694 (15) 98 210 386 56 32 (45–21) 25 12
Countries grouped by estimated TB incidence rate*
 >150/100 000 533 1193 (17) 267 381 545 46 36 (51–24) 30 10
 >200/100 000 428 900 (16) 198 288 414 46 30 (42–20) 34 12
 >200/100 000¶ 554 1252 (14) 250 402 600 48 39 (55–26) 29 11

*From the 2014 WHO Global tuberculosis control report.6

†Percentage of LTBI-positive persons with LTBI treatment.

‡Highest and lowest estimates using the point estimate with (range) of sensitivity, efficacy and adherence estimates.

§Including Somalia, Eritrea and Ethiopia.

¶Includes countries with TB IRs >200/100 000 and Eritrea and Afghanistan (in line with the current Norwegian guidelines).

LTBI, latent tuberculosis infection; TB, tuberculosis.